The tweet was deleted by the author.
But we saved everything 🙂.
CVRx announced the completion of its 6th Barostim implant at The Mount Sinai Hospital, highlighting a growing adoption of its innovative therapy for patients.
The achievement was credited to the efforts of Dr. Johanna Contreras, Dr. Peter Faries, Dr. Christopher Faries, and the hospital team, reflecting increasing momentum for Barostim as a treatment option. The company expressed gratitude for the medical team's dedication to bringing advanced therapies to those in need. Details on patient outcomes or future plans for further Barostim procedures at the facility were not disclosed.
View post on X Loading...
CVRx announced Barostim as an innovative therapy targeting the root mechanisms of heart failure in patients in a previous company release (CVRx unveils Barostim therapy). Earlier, company executive Philip Adamson discussed the evolution of heart failure care treatments in a podcast appearance (Podcast appearance by CVRx executive). These developments follow a series of milestones as Barostim gains traction in clinical settings.